Cargando…
Comparison of Abbott ID NOW, a novel isothermal amplification based COVID-19 diagnostic method with RTPCR
BACKGROUND: The emergent crisis of the COVID-19 pandemic has posed enormous challenges for clinical laboratories to speed up diagnostics. The current reference standard for the diagnosis of COVID-19 is real time reverse transcriptase PCR on various platforms. However, even with automation, the turna...
Autores principales: | Srivastava, Smriti, Singh, Parul, Malhotra, Rajesh, Mathur, Purva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906026/ https://www.ncbi.nlm.nih.gov/pubmed/35278535 http://dx.doi.org/10.1016/j.jviromet.2022.114521 |
Ejemplares similares
-
Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023) -
False-Positive Human Immunodeficiency Virus Reactivity in COVID Patients: A Word of Caution
por: Srivastava, Smriti, et al.
Publicado: (2022) -
Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021) -
Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021) -
Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients
por: Harrington, Amanda, et al.
Publicado: (2020)